1,662 Shares in Teleflex Incorporated (NYSE:TFX) Acquired by Edgestream Partners L.P.

Edgestream Partners L.P. acquired a new position in shares of Teleflex Incorporated (NYSE:TFX) during the 2nd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor acquired 1,662 shares of the medical technology company’s stock, valued at approximately $350,000.

Several other large investors have also recently bought and sold shares of the company. Oregon Public Employees Retirement Fund lifted its holdings in Teleflex by 1.2% during the 2nd quarter. Oregon Public Employees Retirement Fund now owns 4,021 shares of the medical technology company’s stock worth $846,000 after buying an additional 46 shares in the last quarter. Crossmark Global Holdings Inc. lifted its holdings in Teleflex by 1.9% during the 2nd quarter. Crossmark Global Holdings Inc. now owns 2,779 shares of the medical technology company’s stock worth $584,000 after buying an additional 53 shares in the last quarter. KBC Group NV lifted its holdings in Teleflex by 1.8% during the 4th quarter. KBC Group NV now owns 3,173 shares of the medical technology company’s stock worth $791,000 after buying an additional 55 shares in the last quarter. Empirical Finance LLC lifted its holdings in Teleflex by 3.9% during the 1st quarter. Empirical Finance LLC now owns 1,564 shares of the medical technology company’s stock worth $354,000 after buying an additional 58 shares in the last quarter. Finally, SRS Capital Advisors Inc. lifted its holdings in Teleflex by 0.3% during the 2nd quarter. SRS Capital Advisors Inc. now owns 19,527 shares of the medical technology company’s stock worth $4,107,000 after buying an additional 62 shares in the last quarter. Institutional investors and hedge funds own 95.62% of the company’s stock.

Analysts Set New Price Targets

Several research analysts have issued reports on the company. Royal Bank of Canada upped their price objective on Teleflex from $235.00 to $260.00 and gave the stock an “outperform” rating in a report on Friday, August 2nd. Truist Financial increased their price target on Teleflex from $240.00 to $247.00 and gave the company a “hold” rating in a research note on Monday, August 5th. Stephens increased their price target on Teleflex from $275.00 to $290.00 and gave the company an “overweight” rating in a research note on Friday, August 2nd. Finally, Piper Sandler raised Teleflex from a “neutral” rating to an “overweight” rating and increased their price target for the company from $205.00 to $245.00 in a research note on Monday, July 1st. Three research analysts have rated the stock with a hold rating and six have assigned a buy rating to the stock. According to MarketBeat.com, Teleflex currently has a consensus rating of “Moderate Buy” and an average price target of $265.57.

Teleflex Stock Performance

Shares of Teleflex stock opened at $242.50 on Monday. The company has a market capitalization of $11.42 billion, a PE ratio of 38.92, a PEG ratio of 2.23 and a beta of 1.16. Teleflex Incorporated has a 12 month low of $177.63 and a 12 month high of $257.85. The company has a current ratio of 2.58, a quick ratio of 1.44 and a debt-to-equity ratio of 0.36. The stock’s fifty day simple moving average is $235.35 and its 200 day simple moving average is $220.48.

Teleflex (NYSE:TFX) last issued its quarterly earnings data on Thursday, August 1st. The medical technology company reported $3.42 EPS for the quarter, topping the consensus estimate of $3.33 by $0.09. The business had revenue of $749.70 million for the quarter, compared to the consensus estimate of $762.98 million. Teleflex had a return on equity of 14.51% and a net margin of 8.76%. The firm’s revenue was up .9% compared to the same quarter last year. During the same quarter last year, the business posted $3.41 EPS. On average, research analysts predict that Teleflex Incorporated will post 13.97 EPS for the current year.

Teleflex Dividend Announcement

The company also recently announced a quarterly dividend, which was paid on Monday, September 16th. Shareholders of record on Thursday, August 15th were issued a dividend of $0.34 per share. This represents a $1.36 dividend on an annualized basis and a yield of 0.56%. The ex-dividend date was Thursday, August 15th. Teleflex’s dividend payout ratio (DPR) is presently 21.83%.

Insiders Place Their Bets

In other Teleflex news, Director Stuart A. Randle sold 2,674 shares of the stock in a transaction dated Friday, August 16th. The stock was sold at an average price of $238.93, for a total transaction of $638,898.82. Following the completion of the transaction, the director now owns 5,496 shares in the company, valued at approximately $1,313,159.28. The transaction was disclosed in a filing with the SEC, which is available through the SEC website. Corporate insiders own 1.43% of the company’s stock.

Teleflex Company Profile

Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. The company provides vascular access products that comprise Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous access systems for the administration of intravenous therapies, the measurement of blood pressure, and the withdrawal of blood samples through a single puncture site.